Related Experiment Video
Updated: Aug 19, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Epidemiologic and clinical characteristics of Mycobacterium tuberculosis infection in Guangxi, China, 2018-2023: a
Dewu Bi1,2,3, Chaoyou Chen3,4, Hailing Yu1,2,3
1Department of Clinical Laboratory, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Background:
Tuberculosis, caused by Mycobacterium tuberculosis, continues to be one of the leading causes of death globally. We performed a retrospective cohort study in which individuals with suspected tuberculosis were evaluated the differences between tuberculosis and other clinically ill patients.
Methods:
This study retrospectively analyzed patients with suspected tuberculosis who were hospitalized for pneumonia between January 2018 and December 2023 based on an electronic medical records database.
Results:
37,204 patients were included in this study, comprising 34,429 patients with tuberculosis and 2,775 patients with non-tuberculosis lung diseases. Male, human immunodeficiency virus, hepatitis B virus, cytomegalovirus, diabetes, and stroke are risk factors associated with an increased infection of tuberculosis. Poor adherence and human immunodeficiency virus infection are linked to the development of antibiotic resistance in Mycobacterium tuberculosis. Resistance to first-line antibiotics usually appears before second-line treatments, with higher resistance rates for first-line antituberculous drugs than for second-line drugs. Isoniazid resistance developed before rifampicin resistance. The degree of bacterial coinfection among patients with tuberculosis is diverse.
Conclusion:
This study identified risk factors accounting for the infection and drug resistance of tuberculosis in Guangxi, China, from other illness. The diversity of coinfections among patients with tuberculosis highlights the importance of raising awareness about the multiplicity of infections.
Related Concept Videos
Tuberculosis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...